202 related articles for article (PubMed ID: 31288344)
1. [Analysis on the characteristics of suspected vaccine-related deaths in Fujian Province, 2012-2017].
Xiao JX; Lin ZQ; Wu RH; Zhou Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):719-723. PubMed ID: 31288344
[No Abstract] [Full Text] [Related]
2. [Analysis on death from adverse event following immunization surveillance system of Shandong Province during 2011-2016].
Zhang YJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):723-727. PubMed ID: 28763922
[No Abstract] [Full Text] [Related]
3. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
[TBL] [Abstract][Full Text] [Related]
4. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.
Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW
Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493
[TBL] [Abstract][Full Text] [Related]
5. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].
Ye Y; Wang CS; Ma YT; Lu MX; Zhang XX; Zhang YY; Guo WS
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):466-71. PubMed ID: 23791064
[TBL] [Abstract][Full Text] [Related]
6. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
[TBL] [Abstract][Full Text] [Related]
7. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.
Gao D; Dong G; Zhu L; Jia N; Sun B
Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on the adverse event following immunization (AEFI) after supplementary immunization activity of measles attenuated live vaccine in Sichuan province in 2007-2008].
Wang J; Liu QL; Yang CM
Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):219-22. PubMed ID: 20084885
[TBL] [Abstract][Full Text] [Related]
9. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of safety of haemophilus influenza type b(Hib) conjugate vaccine in postmarketing based on the immunization information management system].
Wang Z; Ma F; Zhang J; Yu J; Kang G; Gao J
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):475-80. PubMed ID: 26310329
[TBL] [Abstract][Full Text] [Related]
11. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
12. [Study on surveillance data of adverse events following immunization of seasonal influenza vaccine in China during 2015-2018 influenza season].
Wu WD; Li KL; Xu DS; Ye JK; Xiao QY; Wang HQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):987-992. PubMed ID: 31607043
[No Abstract] [Full Text] [Related]
13. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
[No Abstract] [Full Text] [Related]
14. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
15. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
[No Abstract] [Full Text] [Related]
16. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system.
Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA
Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484
[TBL] [Abstract][Full Text] [Related]
18. [Analysis on the surveillance of adverse events following immunization in China, 2007-2008].
Wu WD; Liu DW; Wu BB
Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):481-90, 538. PubMed ID: 20518320
[TBL] [Abstract][Full Text] [Related]
19. [Adverse events following immunization reported to the district sanitary-epidemiological station in Czestochowa in 2006-2010].
Nowicki D; Gajewska L; Sosada KA
Przegl Epidemiol; 2012; 66(4):667-72. PubMed ID: 23484397
[TBL] [Abstract][Full Text] [Related]
20. Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression.
Lopes SRC; Perin JLR; Prass TS; Carvalho SMD; Lessa SC; Dórea JG
Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29865181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
